Dynex Capital, Inc. (DX) Stock Price & Analysis
Dynex Capital, Inc. (DX) closed at USD 11.05 on Thursday, October 22, 2026, up 1.56% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 10.88; the Oct 22, 2026 session ranged USD 10.89–11.25 on volume of 8,590,011 shares. Market capitalization is $2.74B, with a 52-week range of USD 10.31–14.93 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 11:18 UTC.
Also available as compact Markdown for AI agents: nexqual.com/DX.md
Key facts (DX)
- Valuation: P/E 6.3x (avg 6.7x at the last 2 fiscal year-ends).
- Insider open-market purchases, last ~7 months: 4 Form 4 filings, $295K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 2.17 on a 1–5 scale) (6 analysts), mean target USD 12.6 (range 11.5–14.5).
- Total return with dividends: 1Y -2.3% vs S&P 500 +14.9%; 5Y +20.9% vs S&P 500 +80.3%.
- Next earnings: 2026-10-19, EPS estimate USD 0.37, revenue estimate $105M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (DX)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Net income | $102M | $143M | -$6.1M | $114M | $319M | $436M |
| EPS (diluted) | $2.78 | $3.17 | -$0.25 | $1.49 | $2.47 | — |
| Cash + short-term investments | $366M | $332M | $120M | $377M | $531M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (DX)
P/E 6.3x · P/B 0.9x · Earnings yield 15.91% · Dividend yield (paid, TTM) 13.29%
P/E at fiscal year-ends: Dec 2025 5.5x, Dec 2024 7.9x.
Insider purchases (SEC Form 4, open-market, last ~7 months) (DX)
4 purchases, $295K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-10-20 | Boston Byron L | Co-CEO & Chairman of the Board | 9,180 | $100K | 10.89 | Too little history (no open-market trades in 2023–2025) |
| 2026-10-20 | Popenoe Smriti Laxman | Co-CEO and President | 12,000 | $157K | 13.05 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-10-20 | Sartori Michael Andrew | Chief Financial Officer | 1,000 | $11K | 10.7 | Too little history (no open-market trades in 2023–2025) |
| 2026-09-25 | Connelly Terrence John Jr | Chief Investment Officer | 2,500 | $28K | 11.18 | Too little history (no open-market trades in 2023–2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (DX)
Consensus Buy (mean 2.17 on a 1–5 scale), 6 analysts; mean target USD 12.6 (low 11.5, high 14.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Jones Trading | Target lowered | Buy | $14.75 → $12.5 |
| 2026-10-07 | BTIG | Target lowered | Buy | $14.5 → $12 |
| 2026-07-21 | Jones Trading | Maintained | Buy | $14.75 |
Total return (dividends reinvested) (DX)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -2.3% | +20.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -2.3% | +3.9% |
| Volatility (annualized) | 18.9% | 24.3% |
| Max drawdown | -20.4% (Jan 2026→Oct 2026) | -33.3% (Jul 2022→Oct 2023) |
DX analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $0.37 | $0.38 | -1.5% | $105.4M | 5 |
| Next quarter (ends Mar 2027) | $0.39 | $0.37 | +4.4% | $120.6M | 5 |
| Current fiscal year (ends Dec 2026) | $1.41 | $1.45 | -2.3% | $375.0M | 5 |
| Next fiscal year (ends Dec 2027) | $1.63 | $1.58 | +3.1% | $476.6M | 5 |
DX options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 25.4% | ±10.9% |
| Dec 18, 2026 | 56 | 29.2% | ±11.8% |
| Mar 19, 2027 | 147 | 23.8% | ±13.1% |
30-day implied volatility 16.6% vs 25.9% realized over the last 30 trading days. Put/call ratio (volume) 0.54. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 11:18 UTC)
| Price | USD 11.05 |
|---|---|
| Change | ▲ 1.56% (up) |
| Previous Close | USD 10.88 |
| Open | USD 10.93 |
| Day Range | USD 10.89 – 11.25 |
| 52-Week Range | USD 10.31 – 14.93 |
| Volume | 8,590,011 shares |
| Market Cap | $2.74B |
| Exchange | NYQ |
Technical Analysis (DX)
Nexqual's technical model rates DX "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of October 23, 2026 at 11:18 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.31 (neutral) |
| vs SMA50 | Below (USD 11.99) |
| MACD | -0.29 (negative) |
Analyst Ratings (DX)
Wall Street analysts rate DX "Buy" based on 6 analysts, with a mean price target of USD 12.6 (range USD 11.5–14.5), per Nexqual as of October 23, 2026 at 11:18 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 12.6 |
| High Target | USD 14.5 |
| Low Target | USD 11.5 |
| Buy / Hold / Sell | 4 / 2 / 0 |
Earnings (DX)
| Next Earnings Date | 2026-10-19 |
|---|---|
| EPS Estimate | USD 0.37 |
| Revenue Estimate | $105.43M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 0.38 vs est 0.37 ▲ beat |
| 2026-06-30 | USD 0.36 vs est 0.34 ▲ beat |
| 2026-03-31 | USD 0.31 vs est 0.28 ▲ beat |
| 2025-12-31 | USD 0.22 vs est 0.27 ▼ miss |
Source: Nexqual, October 23, 2026 at 11:18 UTC.
Financials & Fundamentals (DX)
| Total Revenue | $16.95M |
|---|---|
| Gross Margin | +100.00% |
| Operating Margin | +103.90% |
| Profit Margin | -293.46% |
| ROE | -1.99% |
| Debt / Equity | 7.96 |
| Current Ratio | 0.08 |
| Total Cash | $993.01M |
| Total Debt | $24.28B |
Source: Nexqual, October 23, 2026 at 11:18 UTC.
Financial Health Score (DX)
Nexqual rates Dynex Capital, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 11:18 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Strong — Net margin 270% |
| Balance Sheet | Critical — $993M cash vs $24.3B debt |
| Cash Flow | Solid — Operating cash flow $121M (FY ended Dec 2025, 10-K) |
| Efficiency | Critical — ROE -2%, ROA -0.2% |
Ownership (DX)
| Insider Ownership | +0.65% |
|---|---|
| Institutional Ownership | +46.55% |
| Shares Outstanding | 248.17M |
| Float | 257.23M |
| Short % of Float | +7.10% |
Source: Nexqual, October 23, 2026 at 11:18 UTC.
Leadership (DX)
Dynex Capital, Inc. is led by Byron L. Boston, Co-CEO & Chairman of the Board, per Nexqual as of October 23, 2026 at 11:18 UTC.
| Co-CEO & Chairman of the Board | Byron L. Boston |
|---|---|
| Co-CEO, President & Director | Smriti Laxman Popenoe C.F.A. |
| Chief Financial Officer | Michael Sartori |
| Chief Operating Officer | Meakin Bennett |
Major Backers & Investors (DX)
Notable institutional backers of Dynex Capital, Inc. include Millennium Management, Marshall Wace LLP, Fidelity, according to Nexqual as of October 23, 2026 at 11:18 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Millennium Management | 2.84% |
| Marshall Wace LLP | 2.59% |
| Fidelity | 1.43% |
| Ameriprise Financial, Inc. | 1.35% |
| Two Sigma Investments, LP | 1.2% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.45% |
| Vanguard Group | 3.7% |
| Geode Capital | 2.25% |
| State Street | 2.07% |
| Northern Trust | 0.94% |
Source: Nexqual, October 23, 2026 at 11:18 UTC.
From Dynex Capital, Inc.'s Latest SEC 10-K Filing (filed 2026-02-25)
Key Strengths & Strategy (as disclosed to the SEC)
- Delivering value, fostering curiosity, building trust, and being kind allow us to build a winning team.
Partnerships
- In allocating our capital and executing our strategy, we seek to balance the risks of owning specific types of investments with the earnings opportunity on the investment.
- As of December 31, 2025, we did not have more than 10% of equity at risk with any of our repurchase agreement counterparties.
Legal & Regulatory Risks (Item 1A, quoted)
- Compliance with the REIT requirements may limit the type or extent of investment or hedging activities.
- Our ability to invest in taxable subsidiaries is limited under the REIT rules. Maintaining compliance with this limitation could require us to constrain the growth of future taxable REIT affiliates.
- We may be subject to adverse legislative or regulatory tax changes that could increase our tax liability, reduce our operating flexibility, or reduce the market price of our securities.
- The present U.S. federal income tax treatment of REITs may be modified, possibly with retroactive effect, by legislative, judicial, or administrative action at any time, which could affect the U.S. federal income tax treatment of an investment in us. The U.S. federal income tax rules dealing with REITs are constantly under review and subject to frequent revisions to regulations and interpretations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARR | ARMOUR Residential REIT, Inc. | USD 12.69 | ▼ 0.94% |
| BXMT | Blackstone Mortgage Trust, Inc. | USD 10.58 | ▲ 3.73% |
| STWD | STARWOOD PROPERTY TRUST, INC. S | USD 12.58 | ▲ 3.71% |
| RITM | Rithm Capital Corp. | USD 8.68 | ▲ 1.52% |
| EFC | Ellington Financial Inc. | USD 11.63 | ▲ 1.84% |
| LADR | Ladder Capital Corp | USD 9.32 | ▲ 4.02% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 11:18 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt